TRHC CEO Knowlton Named a Fellow of the College of Physicians of Philadelphia

Moorestown, NJ (June 19, 2017) – Tabula Rasa HealthCare (NASDAQ: TRHC) Chairman and CEO, Calvin H. Knowlton, PhD, was inducted into the College of Physicians of Philadelphia at a gala ceremony, May 19, 2017. CCP is known as the “birthplace of American Medicine.”

To become a Fellow means the inductee is “regarded as a learned and dedicated physician, scientist, scholar, practitioner, or provider motivated by the interests of their patients, students, and the public.”

Dr. Knowlton is the Co-founder, Chairman and CEO of Tabula Rasa HealthCare Corporation (TRHC), a healthcare technology company optimizing medication safety by developing new Medication Risk Mitigation™ digital solutions and novel medication decision support tools.

“I am delighted and proud to become a Fellow of the College of Physicians,” said Knowlton. “I look forward to the collegiate purpose of the College, and I appreciate the mission as a place for medical professionals and the general public to learn about medications as both a science and an art. I am eager to share the science, technology and discoveries we at TRHC are producing as we pursue medication risk mitigation and better understanding of adverse drug events.”

Dr. Knowlton has won numerous awards for his leadership in pharmacy, business, and philanthropy in his career of over 30 years, including the 2003 & 2013 Ernest and Young Entrepreneur of the Year Award, Greater Philadelphia Region, and the 2016 Philadelphia Technology CEO of the year. In 2015, Knowlton was awarded the Remington Honor Medal, pharmacy’s highest honor.

Contributing to his profession and the community, Dr. Knowlton has served as the national President for the American College of Apothecaries, President of the American Pharmacists Association (APhA) for two terms, and President of the American Pharmacists Association Foundation. He is the Board Chair of the Evergreens Continuing Care Retirement Community and serves on the Boards of Cooper Medical School of Rowan University and Coriell Institute for Medical Research. He recently finished terms on the Board of St Christopher’s Hospital for Children in Philadelphia and the Settlement Music School.

Dr. Knowlton received his Pharmacy degree from Temple University, his Divinity degree from Princeton Theological Seminary, and his PhD in Pharmacoeconomics from the University of Maryland. He served as Professor and Department Chair for the University of the Sciences in Philadelphia in the 1990s. He has authored and co-authored textbooks, book chapters, and articles focused on the role and responsibility of pharmacists in the outcomes of patient-centered medication care.